Neurology Archives

UNC School of Medicine researchers led an international clinical trial of patients with generalized myasthenia gravis, finding the therapy is safe and effective across all subtypes.

A new clinic will bring ALS care to support the unique needs of individuals living in rural North Carolina.

Experts at the UNC School of Medicine and UNC Eshelman School of Pharmacy are focused on a pain drug candidate that can target an area of the brain that controls the ‘unpleasantness’ associated with pain.

The parents of twins Amelia and Makenzie Kahn, who have been battling Batten disease, a rare genetic disorder, for eight years, are now celebrating signs of progress one year into a first-in-kind clinical study at UNC Health. Led by Yael Shiloh-Malawsky, MD, the new personalized treatment, Zebronkysen, is helping to better manage the disease.

An analysis of Medicare data, led by researchers at the UNC School of Medicine, Duke University School of Medicine, and University of Texas Southwestern Medical Center, reveals that new dementia cases are falling but the number of people living with dementia is rising.

NIH highlights UNC Neurology researcher’s newly developed silent functional MRI (fMRI) technique created to improve biomedical research.

Joseph Piven, MD, the Thomas E. Castelloe Distinguished Professor of Psychiatry and Pediatrics and director of the Carolina Institute for Developmental Disabilities was given the award for his fundamental contributions to research on autism spectrum disorders.

Co-led by UNC School of Medicine’s David Y. Hwang, MD, newly released updated guidelines from the Society of Critical Care Medicine (SCCM) reveal how family centered care for adult ICUs is paramount and an invaluable approach.

Neurologists Winnie K. Lau, MD, and David Y. Hwang, MD, highlight needed research in the emerging field of neuropalliative care.

Using technology first designed by Bryan L. Roth, MD, PhD, the Michael Hooker Distinguished Professor of Pharmacology, researchers at the UNC School of Medicine have engineered a molecular technology that can turn off pain receptors.

Harvard Neuroscientist David D. Ginty, PhD, will receive the Perl-UNC Neuroscience Prize for his pivotal discoveries on the sensation of touch and how our body communicates with the brain.

The lab of Jason Stein, PhD, associate professor of genetics and member of the UNC Neuroscience Center, has created a controlled model system that could help researchers identify the context-dependent functions of genetic variants that increase one’s risk for developing a psychiatric disorder, such as schizophrenia.

Category: Neurology

UNC Study Supports Wider Use of FDA-Approved Drug for Rare Muscle Disease

UNC Health Expands ALS Care to Patients Living in Western North Carolina

A New, Non-Addictive Painkiller is on the Horizon

Family Experiences Unexpected Improvements of Personalized Treatment for Batten Disease

New Study Finds Fewer Americans Are Developing Dementia—But More Are Living with It

UNC Neurology’s Shih Developing Improved, Silent MRI for Better Brain Imaging

Piven Earns Prestigious Lifetime Achievement Award from the International Society for Autism Research

A Fresh Approach to Family-Centered Care for Adult ICUs

Researchers Outline New Research Priorities in Neuropalliative Care

Researchers Create Gene Therapy with Potential to Treat Peripheral Pain Conditions

Ginty Named 23rd Perl-UNC Neuroscience Prize Recipient

Researchers Create New System to Decode Genetic Risk for Psychiatric Disorders